De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Clover Health Investments Beheer
Beheer criteriumcontroles 3/4
De CEO Clover Health Investments' is Andrew Toy, benoemd in Jan2023, heeft een ambtstermijn van 1.75 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 10.15M, bestaande uit 6.9% salaris en 93.1% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.54% van de aandelen van het bedrijf, ter waarde $ 7.55M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.3 jaar en 3.7 jaar.
Belangrijke informatie
Andrew Toy
Algemeen directeur
US$10.2m
Totale compensatie
| Percentage CEO-salaris | 6.9% |
| Dienstverband CEO | 1.8yrs |
| Eigendom CEO | 0.6% |
| Management gemiddelde ambtstermijn | 2.3yrs |
| Gemiddelde ambtstermijn bestuur | 3.7yrs |
Recente managementupdates
Recent updates
There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump
Oct 03
Clover Health: Changing Business Model, Seeking Profitability
Oct 03Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success
Aug 15Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement
Aug 14Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Aug 06Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jun 12Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues
Apr 20Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year
Mar 16Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?
Mar 06Clover Health: Its Luck May Have Ran Out
Feb 26Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Nov 21We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely
Jul 07Chamath Palihapitiya-linked Clover Health Investments trading near all-time low
Oct 14Chamath Palihapitiya cuts stake in Clover Health to under 5%
Oct 04Rethinking My Clover Health Position
Sep 12Clover Paid The Price Of Its Alleged Lies; Time To Move On
Aug 17Clover Health Investments to name president Andrew Toy as CEO
Aug 08Clover Health Is A Buy Ahead Of Earnings
Jul 29Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2
Jul 15Is Clover Health A Good Healthcare Sector Stock Pick?
Jun 30Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$121m |
| Mar 31 2024 | n/a | n/a | -US$157m |
| Dec 31 2023 | US$10m | US$700k | -US$213m |
| Sep 30 2023 | n/a | n/a | -US$234m |
| Jun 30 2023 | n/a | n/a | -US$268m |
| Mar 31 2023 | n/a | n/a | -US$344m |
| Dec 31 2022 | US$10m | US$500k | -US$340m |
| Sep 30 2022 | n/a | n/a | -US$443m |
| Jun 30 2022 | n/a | n/a | -US$402m |
| Mar 31 2022 | n/a | n/a | -US$615m |
| Dec 31 2021 | US$142m | US$450k | -US$588m |
| Sep 30 2021 | n/a | n/a | -US$527m |
| Jun 30 2021 | n/a | n/a | -US$487m |
| Mar 31 2021 | n/a | n/a | -US$160m |
| Dec 31 2020 | US$9m | US$415k | -US$136m |
| Sep 30 2020 | n/a | n/a | -US$89m |
| Jun 30 2020 | n/a | n/a | -US$145m |
| Mar 31 2020 | n/a | n/a | -US$272m |
| Dec 31 2019 | US$424k | US$400k | -US$364m |
Compensatie versus markt: De totale vergoeding ($USD 10.15M ) Andrew } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 5.54M ).
Compensatie versus inkomsten: De vergoeding van Andrew is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Andrew Toy (45 yo)
1.8yrs
Tenure
US$10,154,701
Compensatie
Mr. Andrew Toy Co-founded Clover Health Investments, Corp. and serves as its Director since November 2018 and served as its President since March 2019. He serves as Chief Executive Officer at Clover Health...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 10.3yrs | geen gegevens | 18.14% $ 377.1m | |
| Co-Founder | 1.8yrs | US$10.15m | 0.63% $ 13.2m | |
| General Counsel | less than a year | US$1.47m | 0.22% $ 4.6m | |
| Chief Executive Officer of Home Care | 2.3yrs | US$1.35m | 0.12% $ 2.5m | |
| Chief Executive Officer of Medicare Advantage | 1.8yrs | US$2.49m | 0.22% $ 4.6m | |
| Chief Financial Officer | less than a year | geen gegevens | geen gegevens | |
| Chief Technology Officer | 2.7yrs | geen gegevens | 0.57% $ 11.9m | |
| Head of Investor Relations & Corporate strategy | no data | geen gegevens | geen gegevens | |
| Chief Compliance Officer | no data | geen gegevens | geen gegevens | |
| Chief People Officer | no data | geen gegevens | geen gegevens | |
| Chief Medical Officer of Clover Assistant | 2.9yrs | geen gegevens | geen gegevens | |
| Chief Medical Officer | 3.8yrs | geen gegevens | geen gegevens |
2.3yrs
Gemiddelde duur
46yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van CLOV wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.3 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 10.3yrs | geen gegevens | 18.14% $ 377.1m | |
| Co-Founder | 5.9yrs | US$10.15m | 0.63% $ 13.2m | |
| Independent Director | 3.8yrs | US$280.93k | 0.067% $ 1.4m | |
| Independent Director | 7.7yrs | US$246.55k | 0.067% $ 1.4m | |
| Board Observer | no data | geen gegevens | geen gegevens | |
| Independent Director | 3.6yrs | US$268.43k | 0.051% $ 1.1m | |
| Independent Director | 2.3yrs | US$250.30k | 0.041% $ 861.3k | |
| Independent Director | 1.9yrs | US$247.80k | 0.078% $ 1.6m | |
| Lead Independent Director | 3.5yrs | US$320.16k | 0.045% $ 930.5k |
3.7yrs
Gemiddelde duur
48yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van CLOV wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).